
Semrush Announces Second Quarter 2025 Financial Results
Semrush Holdings, Inc. (NYSE: SEMR), a leading online visibility management SaaS platform, today reported financial results for the second quarter ended June 30, 2025.
August 4, 2025
You are using services from digiseotools.com.
If you are here from another website, Please let us know.
Three months ended June 30, | Six months ended June 30, | ||||||
2022 | 2021 | 2022 | 2021 | ||||
Revenue | $ 62,610 | $ 45,005 | $ 119,738 | $ 85,003 | |||
Cost of revenue ¹ | 12,598 | 10,238 | 24,185 | 19,011 | |||
Gross profit | 50,012 | 34,767 | 95,553 | 65,992 | |||
Operating expenses | |||||||
Sales and marketing ¹ | 30,894 | 18,298 | 56,724 | 34,755 | |||
Research and development ¹ | 9,671 | 5,964 | 17,809 | 11,322 | |||
General and administrative ¹ | 14,218 | 10,520 | 28,381 | 18,424 | |||
Exit costs | 3,485 | — | 3,485 | — | |||
Total operating expenses | 58,268 | 34,782 | 106,399 | 64,501 | |||
(Loss) income from operations | (8,256) | (15) | (10,846) | 1,491 | |||
Other income (expense), net | 711 | (123) | 870 | (72) | |||
(Loss) income before income taxes | (7,545) | (138) | (9,976) | 1,419 | |||
Provision for income taxes | 739 | 141 | 879 | 227 | |||
Net (loss) income | $ (8,284) | $ (279) | $ (10,855) | $ 1,192 | |||
Net (loss) income per share attributable to common stockholders: | |||||||
Basic | $ (0.06) | $ — | $ (0.08) | $ 0.01 | |||
Diluted | $ (0.06) | $ — | $ (0.08) | $ 0.01 | |||
Weighted-average number of shares of common stock used in computing net (loss) income per share attributable to common stockholders: | |||||||
Basic | 141,042 | 135,312 | 140,921 | 115,951 | |||
Diluted | 141,042 | 135,312 | 140,921 | 137,263 | |||
¹ includes stock-based compensation expense as follows: |
Three months ended June 30, | Six months ended June 30, | ||||||
2022 | 2021 | 2022 | 2021 | ||||
Cost of revenue | $ 21 | $ 7 | $ 32 | $ 14 | |||
Sales and marketing | 277 | 52 | 410 | 242 | |||
Research and development | 358 | 68 | 507 | 135 | |||
General and administrative | 1,548 | 442 | 2,187 | 771 | |||
Total stock-based compensation | $ 2,204 | $ 569 | $ 3,136 | $ 1,162 | |||
Three months ended June 30, | Six months ended June 30, | ||||||
2022 | 2021 | 2022 | 2021 | ||||
Reconciliation of Non-GAAP net (loss) income | |||||||
Net (loss) income | $ (8,284) | $ (279) | $ (10,855) | $ 1,192 | |||
Stock-based compensation expense | 2,204 | 569 | 3,136 | 1,162 | |||
Non-GAAP net (loss) income | $ (6,080) | $ 290 | $ (7,719) | $ 2,354 |
As of | |||
June 30, 2022 | December 31, 2021 | ||
Assets | |||
Current assets | |||
Cash and cash equivalents | $ 248,917 | $ 269,665 | |
Accounts receivable | 2,346 | 2,190 | |
Deferred contract costs, current portion | 7,276 | 6,338 | |
Prepaid expenses and other current assets | 10,484 | 5,345 | |
Total current assets | 269,023 | 283,538 | |
Property and equipment, net | 8,632 | 8,270 | |
Intangible assets, net | 11,344 | 2,925 | |
Goodwill | 6,740 | 1,991 | |
Deferred contract costs, net of current portion | 2,586 | 2,254 | |
Other assets | 3,921 | 1,096 | |
Total assets | $ 302,246 | $ 300,074 | |
Liabilities and stockholders’ equity | |||
Current liabilities | |||
Accounts payable | $ 5,729 | $ 9,942 | |
Accrued expenses | 25,309 | 19,479 | |
Deferred revenue | 48,303 | 40,232 | |
Other current liabilities | 2,621 | 1,896 | |
Total current liabilities | 81,962 | 71,549 | |
Long-term liabilities | |||
Deferred revenue, net of current portion | 185 | 237 | |
Deferred tax liability | 24 | 268 | |
Other long-term liabilities | 2,179 | 2,478 | |
Total liabilities | 84,350 | 74,532 | |
Stockholders' equity | |||
Class A common stock, $0.00001 par value - 1,000,000,000 shares authorized, and 43,261,183 shares issued and outstanding as of June 30, 2022; 31,841,861 shares issued and outstanding as of December 31, 2021 | — | — | |
Class B common stock, $0.00001 par value - 160,000,000 shares authorized, and 97,975,754 shares issued and 97,870,664 outstanding as of June 30, 2022; 108,975,216 shares issued and 108,870,126 outstanding as of December 31, 2021 | 1 | 1 | |
Additional paid-in capital | 269,201 | 264,871 | |
Accumulated other comprehensive deficit | (1,351) | (230) | |
Accumulated deficit | (49,955) | (39,100) | |
Total stockholders’ equity | 217,896 | 225,542 | |
Total liabilities and stockholders' equity | $ 302,246 | $ 300,074 |
Six Months Ended | |||
June 30, | |||
2022 | 2021 | ||
Operating Activities | |||
Net (loss) income | $ (10,855) | $ 1,192 | |
Adjustments to reconcile net (loss) income to net cash provided by operating activities | |||
Depreciation and amortization expense | 4,221 | 1,447 | |
Amortization of deferred contract costs | 4,763 | 2,950 | |
Stock-based compensation expense | 3,136 | 1,162 | |
Non-cash interest expense | 53 | 104 | |
Change in fair value of convertible debt securities | (1,028) | — | |
Deferred taxes | 202 | (83) | |
Changes in operating assets and liabilities | |||
Accounts receivable | 109 | (1,324) | |
Deferred contract costs | (6,033) | (4,789) | |
Prepaid expenses and other current assets | (4,874) | (4,530) | |
Other current liabilities | 1,589 | — | |
Accounts payable | (2,714) | 720 | |
Accrued expenses | 4,818 | 4,981 | |
Deferred revenue | 7,240 | 8,229 | |
Other long-term liabilities | (38) | — | |
Net cash provided by operating activities | 589 | 10,059 | |
Investing Activities | |||
Purchases of property and equipment | (2,798) | (750) | |
Purchases of convertible debt securities | (2,000) | (500) | |
Capitalization of internal-use software development costs | (782) | (271) | |
Cash paid for acquisition of assets and businesses, net of cash acquired | (13,993) | (350) | |
Net cash used in investing activities | (19,573) | (1,871) | |
Financing Activities | |||
Proceeds from exercise of stock options | 1,194 | 26 | |
Net proceeds from completing initial public offering | — | 137,467 | |
Payment of capital leases | (1,445) | (453) | |
Net cash (used in) provided by financing activities | (251) | 137,040 | |
Effect of exchange rate changes on cash and cash equivalents | (1,513) | — | |
(Decrease) increase in cash, cash equivalents and restricted cash | (20,748) | 145,228 | |
Cash, cash equivalents and restricted cash, at beginning of period | 269,841 | 35,619 | |
Cash, cash equivalents and restricted cash, at end of period | $ 249,093 | $ 180,847 |